Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson: Third Time’s Not the Charm for Expanded Xarelto Approval
Wall St Cheat Sheet
Monday, January 20, 2014 - 11:11am
tags:
JNJ, Xarelto, bloodthinners, FDA
Nektar presents data from Phase l study of etirinotecan pegol
Yahoo/Fly on the Wall
Monday, January 20, 2014 - 11:09am
tags:
Nektar, etirinotecan pegol, NKTR-102, advanced cancer
GCVRZ: Betting On The Sales Of Lemtrada In A Moving MS Drug Market
Seeking Alpha
Sunday, January 19, 2014 - 2:58pm
tags:
Genzyme, Lemtrada, MS
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies
Seeking Alpha
Sunday, January 19, 2014 - 2:50pm
tags:
Thermo Fisher, Life Technologies, Jiangsu Aosaikang Pharma, Wuhan Kindstar Clinical Diagnostics, TaiGen Biotechnology, Actavis, GSK, Neuralstem, EntreMed
Big Pharma may cut South African investment in generics row
Business Day
Saturday, January 18, 2014 - 11:31am
tags:
generics
When Numerous Biotechs Populate The New Highs List
Forbes
Saturday, January 18, 2014 - 11:23am
tags:
Biocon to start selling breast cancer drug in India in February
Yahoo/Reuters
Saturday, January 18, 2014 - 11:21am
tags:
Biocon, breast cancer, trastuzumab, generics, Herceptin
Actavis to Sell Some European Operations to Aurobindo Pharma
Bloomberg
Saturday, January 18, 2014 - 11:20am
tags:
Actavis, Aurobindo, M&A
FDA OKs mental disability blood test for infants
Yahoo/AP
Saturday, January 18, 2014 - 11:16am
tags:
Affymetrix, Downs Syndrome, DiGeorge syndrome, mental illness
Gilead Is Not Done; There Is Potentially 50% More Upside This Year
Seeking Alpha
Saturday, January 18, 2014 - 11:01am
tags:
Gilead Sciences
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Friday, January 17, 2014 - 5:54pm
tags:
JPMHC 2014, Algeta, Macrogenics, Xencor, Acetylon, Enanta Pharmaceuticals, Clinigen, Iroko Pharmaceuticals, Protalix BioTherapeutics, Ambrx, Roche, Sialix, Verastem, pRED, Cubist Pharmaceuticals, Celgene, Otonomy, Lumena Pharmaceuticals
$1.3M is the tip of the pay iceberg for new Teva CEO
Fierce Pharma
Friday, January 17, 2014 - 5:47pm
tags:
Teva, Pharma CEOs, Erez Vigodman, executive pay
Drugmakers see innovation justifying further price rises
Reuters
Friday, January 17, 2014 - 5:44pm
tags:
innovation, Biomarin, Roche, Herceptin, Biogen Idec
Novartis employees may have violated trial protocol in Japan
Reuters
Friday, January 17, 2014 - 5:39pm
tags:
Novartis, Japan, clinical trials
4 Biotech Stocks Making Big Moves
Wall St Cheat Sheet
Friday, January 17, 2014 - 5:31pm
tags:
Halozyme, Pacific Biosciences, Keryx, Intercept Pharma
Intercept Pharmaceuticals' Above $300 -- More Mega Millions On The Way?
Forbes
Friday, January 17, 2014 - 5:28pm
tags:
OCA, Intercept Pharma
FDA Grants Earlier Than Expected Approval For Medtronic's CoreValve
Forbes
Friday, January 17, 2014 - 5:24pm
tags:
FDA, Medtronic, CoreValve
FDA Approvals Strong in 2013, but Far From Highs of 2012
Regulatory Focus
Friday, January 17, 2014 - 9:18am
tags:
drug approvals, FDA
Tekmira's Shorter Path To Profitability
Seeking Alpha
Friday, January 17, 2014 - 9:16am
tags:
Tekmira Pharmaceuticals, drug delivery, nucleic acid delivery
Spotlight 2014-Biotech CytRx Corporation
Seeking Alpha
Friday, January 17, 2014 - 9:14am
tags:
CytRx, aldoxorubicin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.